A Study of IBI362 in Participants With Obesity or Overweight

Clinical trial NCT05607680 · COMPLETED

Trial details

NCT number: NCT05607680
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Or Overweight

Start date: 2022-11-14
Primary completion: 2023-08-21
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.